Axogen announces first surgical implants of avive+ soft tissue matrix™

Alachua, fla. and tampa, fla., april 29, 2024 (globe newswire) -- axogen, inc. (nasdaq: axgn), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, avive+ soft tissue matrix™.
AXGN Ratings Summary
AXGN Quant Ranking